导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.60% | 619/1050 |
| 近一周 | -1.53% | 571/1104 |
| 近一月 | -3.13% | 554/1103 |
| 近一季 | -6.04% | 518/1092 |
| 近半年 | -2.74% | 546/1070 |
| 近一年 | 0.56% | 583/1018 |
| 近两年 | 38.63% | 604/926 |
| 近三年 | 3.26% | 647/834 |
| 成立以来 | 62.95% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.27% 731/1070 |
13.20% 492/1101 |
- - |
- - |
| 2025 | 24.68% 585/1065 |
4.69% 429/1014 |
3.60% 387/1038 |
15.09% 739/1050 |
-0.11% 461/1065 |
| 2024 | -10.58% 776/1011 |
-3.95% 533/960 |
-5.55% 665/983 |
11.31% 522/991 |
-11.45% 938/1011 |
| 2023 | -6.56% 241/952 |
7.19% 209/880 |
-2.96% 371/895 |
-4.59% 274/915 |
-5.85% 596/952 |
| 2022 | -25.25% 504/867 |
-14.10% 219/773 |
5.83% 469/806 |
-13.72% 500/845 |
-4.70% 637/867 |
| 2021 | 22.69% 137/740 |
0.83% 117/580 |
11.51% 317/659 |
5.53% 117/704 |
3.40% 282/740 |
| 2020 | 47.34% 251/554 |
1.70% 118/419 |
21.53% 260/466 |
10.39% 245/517 |
7.99% 391/554 |
| 2019 | 41.74% 208/410 |
23.32% 821/1146 |
-1.09% 447/1228 |
4.87% 201/390 |
10.81% 141/410 |
| 2018 | - - |
- - |
-1.66% 109/990 |
-8.62% 682/1000 |
-10.11% 304/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 海富通量化前锋股票A VS. 东吴新产业精选股票A(580008) |